As the global obesity epidemic grows, it exerts profound effects on health, economies, and societies. The rising obesity rate is not only a health crisis but also a multifaceted challenge that intersects with economic burden and social disparities. Obesity is fundamentally linked to endocrine disorders, affecting hormones and metabolic processes critical to human health. Obesity significantly increases the risk for various chronic diseases—including infertility, type 2 diabetes, cardiovascular and pulmonary diseases, hypertension, and certain cancers—by disrupting metabolic and hormonal balance, promoting inflammation, and altering the body's normal functions. Addressing all aspects of obesity, which necessitates a broad approach in research and treatment, is crucial to prevent these associated health conditions and improve overall health outcomes.
The current landscape of obesity research is dynamic and rapidly evolving, reflecting the complex nature of obesity and the urgent need for effective therapies. There have recently been substantial advancements in understanding the biological pathways that regulate appetite, energy balance, and metabolism. This has helped develop new therapeutic strategies targeting different aspects of obesity, from appetite suppression to energy expenditure, from fat absorption to muscle mass preservation. Additionally, integrating digital health tools and personalized medicine approaches is becoming increasingly important in obesity management. These technologies can offer tailored dietary, exercise, and behavioral interventions, enhancing the effectiveness of pharmacological treatments and addressing the multifaceted nature of obesity.
Acknowledging and sharing scientific data on obesity's complexity is an important step toward innovative solutions to address the epidemic's roots and far-reaching consequences. Remarkable recent growth in obesity research is evidenced by the increasing number of articles published on obesity and metabolic disorders, with citations doubling over the past 5 years. This surge showcases the field's dynamism and its critical integration within the broader scope of endocrine studies. Interdisciplinary research can enhance understanding of obesity's role in endocrine diseases and promote the development of innovative treatments.
Researching and understanding all of these aspects of obesity align with JES's mission to advance medical science and improve patient care. Recognizing the growth in obesity research, we recently compiled a special collection of obesity-related articles published in JES (https://academic.oup.com/jes/pages/obesity). As a journal that publishes along the entire spectrum of research, from pure basic science to clinical to outcomes studies, we feel that JES is the ideal home for articles published on obesity. With the addition of our new associate editor, Dr Furkan Burak, on this topic and by encouraging submissions across a wide spectrum of obesity-related topics, our goal is to cultivate a rich and diverse discourse that reflects the complexity of the condition and fosters research excellence in the endocrinology of obesity. This approach ensures that we share high-quality research representing all facets of obesity, from molecular mechanisms to societal effects, enriching the field with varied perspectives and innovative solutions.
Despite scientific advances in obesity research, challenges remain in developing safe and effective obesity therapies. Thus, we issue a strong call to action for the scientific and medical communities to pursue the boundaries of obesity research and treatment relentlessly. The heterogeneity of obesity, with its various contributing factors, including genetics, lifestyle, and environmental influences, requires broad approaches. Moreover, the long-term safety and efficacy of emerging therapies must be established through rigorous clinical trials. Despite the recent emergence of novel, effective treatments, worldwide access to these treatments remains poor. Given the number of individuals with obesity and the current economic landscape of the obesity market, there is a race to bring untouched, previously nontargeted mechanism-of-action, genome-wide association study targets to clinic. We encourage the scientific community to maintain high standards of evidence, generate reproducible, robust data, and collaborate and share their resources such that we can effectively advance the obesity field worldwide. As research progresses, it is critical to ensure that these advances are accessible to the diverse populations affected by obesity, addressing not only physical but also psychological and societal dimensions of the disease. JES pledges its commitment to remain at the vanguard of disseminating groundbreaking research and fostering the development of effective solutions for obesity while increasing its accessibility. Through collective efforts and a shared vision, we can achieve significant strides in overcoming obesity and enhancing the well-being of individuals worldwide.
Disclosures
Z.M.E. is editor-in-chief, S.R.H. is deputy editor, and M.F.B. is an associate editor of Journal of the Endocrine Society.
Contributor Information
Zeynep Madak-Erdogan, Email: zmadake2@illinois.edu, Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Stephen R Hammes, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
M Furkan Burak, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Molecular Metabolism, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.